A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 29
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PDE5i
Long Form : PDE5 inhibitors
No. Year Title Co-occurring Abbreviation
2022 The NO/cGMP/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders. cGMP, GC, NO, P2Y12, PDE5, PDEs
2021 Priming metabolism with the type 5 phosphodiesterase: the role of cGMP-hydrolyzing enzymes. cGMP, PDEs
2019 Adherence and barriers to penile rehabilitation over 2 years following radical prostatectomy. ED, PR, VCD
2019 Cyclic nucleotide phosphodiesterases (PDEs) and endothelial function in ischaemic stroke. A review. PDE, PDE3i, PDE4i, PDEs
2019 Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled, proof-of-concept trial. ANP, PAH
2019 Potential for Long-Term Benefit of Cognitive Behavioral Therapy as an Adjunct Treatment for Men with Erectile Dysfunction. CBT, ED, PDE5
2019 Regulation of PDE5 expression in normal prostate, benign prostatic hyperplasia, and adenocarcinoma. BPH, PCa
2019 Screening of illegal sexual enhancement supplements and counterfeit drugs sold in the online and offline markets between 2014 and 2017. ED
2018 Novel Treatment for Premature Ejaculation in the Light of Currently Used Therapies: A Review. IELT, PE, PEP
10  2018 Synergistic interaction between a PDE5 inhibitor (sildenafil) and a new adenosine A2A receptor agonist (LASSBio-1359) improves pulmonary hypertension in rats. A2AR, MCT, PAs, PH, RV
11  2018 The two phases of the clinical validation of preclinical translational mechanistic research on PDE5 inhibitors since Viagra's advent. A personal perspective. CLTA, CVOD, ED, PD
12  2016 PDE5 Inhibition Ameliorates Visceral Adiposity Targeting the miR-22/SIRT1 Pathway: Evidence From the CECSID Trial. EAT, SIRT1, VAT
13  2015 Does testosterone supplementation increase PDE5-inhibitor responses in difficult-to-treat erectile dysfunction patients? AR, ED
14  2015 Erectile dysfunction and phosphodiesterase type 5 inhibitor use: associations with sexual activities, function and satisfaction in a population sample of older men. ---
15  2015 PDE-5 inhibitors in monotherapy versus combination therapy in a sample of 1200 patients with erectile dysfunction. TES
16  2015 Phosphodiesterase type 5 inhibitors: back and forward from cardiac indications. CAD, ED, PAH
17  2014 Sildenafil attenuates inflammation and oxidative stress in pelvic ganglia neurons after bilateral cavernosal nerve damage. IL-1, iNOS, MPG, MPO, NADPH, TGF-beta1
18  2012 Effects of sildenafil and/or muscle derived stem cells on myocardial infarction. LVEF, MDSC
19  2011 Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats. ETB, HIF-1alpha, LUT, PDE5, SHR, WKY
20  2011 Tadalafil alters energy metabolism in C2C12 skeletal muscle cells. ED, PDEs
21  2010 Exposure to phosphodiesterase type 5 inhibitors stimulates aromatase expression in human adipocytes in vitro. ARO, PDE5, qRT-PCR
22  2010 Recreational use of phosphodiesterase type 5 inhibitors by healthy young men. ---
23  2009 A literature review and case reports series on the use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction. ---
24  2008 Endothelial rehabilitation: the impact of chronic PDE5 inhibitors on erectile function and protein alterations in cavernous tissue of diabetic rats. ED, SELDI
25  2007 Which patients with sexual dysfunction are suitable for testosterone replacement therapy? cGMP, ED, LOH, NOS, PDE5, SD, TDS
26  2006 The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems. ED, FDA, PDE5
27  2005 Erectile dysfunction: molecular biology, pathophysiology and pharmacological treatment. cGMP, ED, PDE5
28  2005 PDE5 inhibitors and permanent visual loss. NAION
29  2003 An update on the PDE-5 inhibitors (PDE-5i). ---